상세 보기
자료 필터
자료유형
발행연도
2010 ~ 2030
2010 2030
키워드
언어
전체 172건 중 41번부터 50번까지의 결과를 표시합니다.
2024
Conference
Circulating tumor DNA as a biomarker for neratinib and trastuzumab efficacy in HER2-mutated advanced solid tumors: Insights from KCSG AL20-17/KM23 phase II trial
- Lee, K. ;
- Lee, K-H. ;
- Kim, D-W. ;
- Yoon, J. S. ;
- Choi, W. ;
- ... Choi, Y. J. ;
- ... Lee, S. ;
- ... Kim, J. W. ;
- ... Kang, E. J. ;
- ... Park, I. H. ;
- 외 10명
- 2024-09
- 네덜란드
Article
Early Integrated Palliative Care in Patients With Advanced Cancer: A Randomized Clinical Trial
- Kang, Eunkyo ;
- Kang, Jung Hun ;
- Koh, Su-Jin ;
- Kim, Yu Jung ;
- Seo, Seyoung ;
- ... Kang, Eun Joo ;
- 외 11명
- 2024-08
- Jama Network Open
- AMER MEDICAL ASSOC
Conference
ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17).
- Yang, Yaewon ;
- Kang, Eun Joo ;
- Lee, Soohyeon ;
- Kim, Yu Jung ;
- Lim, Sun Min ;
- ... Park, Kyong Hwa ;
- 외 10명
- 2024-06-01
- 미국
Conference
Phase II study to evaluate safety and efficacy of neratinib, an irreversible pan-HER tyrosine kinase inhibitor, and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors (KCSG AL20-17).
- Lee, Kyoungmin ;
- Lee, Kyung-Hun ;
- Kim, Dong-Wan ;
- Yoon, Jeesun ;
- Choi, Wonyoung ;
- ... Choi, Yoon Ji ;
- ... Lee, Soohyeon ;
- ... Kim, Ju Won ;
- ... Kang, Eun Joo ;
- ... Park, Inhae ;
- 외 10명
- 2024-06-01
- 미국